| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |